Clinical Trial Update: Use of Hemopatch as a Sealant at the Pancreaticojejunostomy After Pancreatoduodenectomy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing Hemopatch as a sealant at pancreaticojejunostomy after pancreatoduodenectomy for preventing pancreatic fistula.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Fistula

Drugs mentioned

• Hemopatch

Snippet

Sponsor: Hospital Miguel Servet | Conditions: Pancreatic Fistula | Phase 3 | Status: COMPLETED